1. The costs incurred by the NHS in England due to the unnecessary prescribing of dependency-forming medications
- Author
-
Joanna Moncrieff, Luke Montagu, Todd C. Rae, Ruth Cooper, Mamata Parhi, and James Davies
- Subjects
Adult ,medicine.medical_specialty ,Medicine (miscellaneous) ,BF ,Primary care ,Toxicology ,Drug Prescriptions ,Drug Costs ,State Medicine ,HJ ,RS ,Humans ,Medicine ,Medication monitoring ,Medical prescription ,business.industry ,Public health ,Guideline ,National health service ,Psychiatry and Mental health ,Clinical Psychology ,Cross-Sectional Studies ,Pharmaceutical Preparations ,Emergency medicine ,business ,Annual loss - Abstract
This cross-sectional study estimates the costs incurred by the National Health Service (NHS) in England as a consequence of the unnecessary prescribing (i.e. non-indicated or dispensable) of dependency-forming medicines (antidepressants, opioids, gabapentinoids, benzodiazepines, Z-drugs). It assesses prescribing in primary care from April 2015-March 2018. Analyses were based upon the following data sets: the number of adults continuously prescribed dependency forming medications and the duration of prescriptions (obtained from Public Health England); the Net Ingredient Cost (NIC) and the dispensing costs for each medicine (obtained from the NHS Business Service Authority [NHSBSA]). Consultation costs were calculated based on guideline recommendations and the number of consultations evidenced in prior research for long-term medication monitoring. Across opioids, gabapentinoids, benzodiazepines, Z-drugs the total estimated unnecessary cost over three years (April 2015-March 2018) was £1,367,661,104 to £1,555,234,627. For antidepressants the total estimated unnecessary cost for one year was £37,321,783 to £45,765,504. The data indicate that the NHS in England may incur a significant estimated mean annual loss of £455,887,035 to £518,411,542 for opioids, gabapentinoids, benzodiazepines, Z-drugs and an estimated annual loss of £37,321,783 to £45,765,504 for antidepressants. Combined, this gives an estimated annual loss of £493,208,818 to £564,177,046 as a result of non-indicated or dispensable prescribing of dependency-forming medicines. Estimates are conservative and figures could be higher.
- Published
- 2022